Guidelines from the American College of Physicians indicate that a restrictive red blood cell transfusion strategy is recommended for hospitalized patients with coronary heart disease with the trigger hemoglobin threshold lowered to 7-8 g/dL. This guidance also stipulates that erythropoiesis-stimulating agents are not recommended for patients with mild to moderate anemia and either congestive heart failure or coronary heart disease.
Although restriction of activity is usually not required for iron deficiency anemia, it is recommended in patients with moderately severe iron deficiency anemia and significant cardiopulmonary disease until the anemia is adequately addressed with iron therapy.
Learn more about iron deficiency anemia treatment and management.
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: James L. Harper. Fast Five Quiz: Iron Deficiency Anemia Management - Medscape - Aug 06, 2021.